Strong commitment for TARGET BP clinical program to help address uncontrolled hypertension. ablativesolutions.com

Prof. Horst Sievert presented Peregrine Post-Market study results for the CE-marked Peregrine Catheter at #CRT2019 on behalf of European investigators. tinyurl.com/y2an489p

Ablative Solutions is pleased to announce that Kate Rumrill has joined the company as President and CEO. bwnews.pr/2LJK58F

First Patient Enrolled and Randomized in Global #ClinicalTrial Evaluating Ablative Solution’s Novel Therapy for Uncontrolled #Hypertension - TARGET BP Clinical Program studies #renaldenervation using the investigational Peregrine System Kit prn.to/2OdeKxM

We invite you to join Prof. Horst Sievert’s Featured Live Case Presentation at TCT on Thurs, Oct 15th at 12:40 EST: Renal Denervation with Alcohol (Peregrine System Kit). #TCT2020 #TCTConnect #hypertension #interventionalcardiology #highbloodpressure tctconnect.com/tct-full-progr…

We are just an hour away from Professor Horst Sievert’s live presentation on Renal Denervation with Alcohol. This is a presentation you will not want to miss. #TCTConnect #hypertension #interventionalcardiology #highbloodpressure tctconnect.com/tct-innovation…

Looking forward to Stefan Bertog's presentation Wed AM #EuroPCR #hypertension bit.ly/22fAiGE

Transcath perivasc. alcohol denervation addresses technical challenges of energy-based #renaldenervation #EuroPCR

Congratulations to Robert Fischell on Medal of Tech & Innovation from President Donald J. Trump! x.com/AcadofInventor…

FDA Allows Ablative Solutions to Initiate Phase 2 TARGET-BP I Trial of Combo Drug/Device Tx for Hypertension under IND bit.ly/2coHa2q

Felix Mahfoud shares Peregrine Post-Market Study results at #CRT2018 and announces plans for TARGET BP OFF-MED Clinical Trial.

Congratulations to Dr. Tim Fischell for being inducted as a Fellow of the National Academy of Inventors! #NAI2018 Ablative Solutions #medtech #innovation